Back to News
Market Impact: 0.45
Karyopharm Therapeutics Inc. Files for Chapter 11 Bankruptcy on November 2, 2026
Source: Nasdaq
Healthcare & BiotechM&A & RestructuringLegal & LitigationCompany Fundamentals
On November 2, 2026, Karyopharm Therapeutics Inc. and its subsidiary KPT Texas LLC filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division. The available article text provides no further details on the restructuring or its financial effects.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.85
Ticker Sentiment
KPTI-0.95
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell-Lumentum Deal Puts Optical Networking at the Center of the AI Boom
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history